AbbVie Gains New Immunology Antibody Platform With DJS Buy

 
• By Jessica Merrill

Deal Snapshot: AbbVie will acquire the privately-held UK antibody developer with preclinical assets.

magnent pulling people
AbbVie plans to keep the talent and the science behind DJS • Source: Shutterstock

More from Deals

More from Business